Brier, Matthew R.
Day, Gregory S.
Snyder, Abraham Z.
Tanenbaum, Aaron B.
Ances, Beau M.
Funding for this research was provided by:
National Institutes of Health (R01NR12657, R01NR012907, R01NR014449)
National Institutes of Health (P30NS048056)
Niess-Gain Family Endowment for Alzheimer disease research
Paula and Rodger O Riney Fund
Alzheimer's Association
Weston Brain Institute (Eugene M. Johnson, Jr. Postdoctoral Fellowship)
Article History
Received: 18 January 2016
Revised: 26 February 2016
Accepted: 27 February 2016
First Online: 30 March 2016
Compliance with ethical standards
:
: The authors have no conflict of interest. GSD is the clinical director of the Anti-NMDA Receptor Encephalitis Foundation; the Foundation is supported by private donations.